Original-Research: Marley Spoon Group SE - from NuWays AG

Classification of NuWays AG to Marley Spoon Group SE

Company Name: Marley Spoon Group SE
ISIN: LU2380748603

Reason for the research: Update
Recommendation: Kaufen
from: 02.05.2024
Target price: EUR 7.00
Target price on sight of: 12 Monaten
Last rating change:
Analyst: Mark Schüssler

Healthy Q1 results // FY'24 guidance confirmed; chg.

On Tuesday, Marley Spoon Group ('MSG') released healthy Q1’24 and final FY'23 consolidated results that were in line with expectations. Q1’24 sales came in at € 80.7m or -12% yoy (excluding bistroMD c. € 76m; eNuW: € 75.6m). Cautious consumer behavior in the meal-kit segment continued to weigh on sales as the number of active subscribers fell 23% yoy to 194k (eNuW: 189k) - the effect of which was more pronounced for Europe and Australia than for the US – while revenue from bistroMD partially offset this decline and had a noticeable impact on Q1’24 group sales of c. € 5m (eNuW).

Importantly, after several quarters of decline, MSG was able to observe bottoming-out effects in its subscriber base (+0.5% qoq) as well as a recovery in both order frequency (+5% qoq to 6.5; +2% yoy) and basket size (+3% qoq to € 64; +11% yoy) indicating a return to healthy growth and KPI levels. This positive development was overwhelmingly driven by (1) a higher-quality subscriber base with enhanced retention levels on the back of a rectified voucher strategy in H2’23, (2) higher-priced and largersized plan items and (3) an overall stabilizing consumer sentiment.

While topline headwinds persisted, MSG managed to expand its industry-leading contribution margin in Q1 to 34.4% (+335bps yoy, eNuW: 32.5%) on account of reduced voucher and promotional activity and first cost savings in fulfilment (-37% yoy to € 9.2m) derived from the FreshRealm partnership. Notably, MSG translated a higher contribution margin into a healthy operating EBITDA margin of 0.2% for Q1 (c. +700bps yoy) impacted by an increased marketing efficiency (-33% yoy to € 13.8m) and a more streamlined G&A setup (-3% yoy to c. € 21.5m excluding one-offs) as cost reduction measures from automation, centralization, and the closure of underutilized operations began to kick in.

This promising Q1 performance led the company to confirm its FY’24 guidance, expecting sales to grow by a single-digit percentage figure (eNuW: +9% yoy) and a flat contribution margin of c. 31.5% (eNuW: 31.8%). Operating EBITDA is seen to grow to a positive mid-single-digit figure (eNuW: € 2m). In our view, this guidance looks achievable and - aided by a promising strategic outlook and operational progress towards group profitability - MSG looks set to disproportionately benefit from an eventual return of consumer confidence.

We reiterate our BUY rating with an unchanged PT of € 7.00 based on DCF.

You can download the research here:
http://www.more-ir.de/d/29579.pdf
For additional information visit our website www.nuways-ag.com/research.

Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++

-------------------transmitted by EQS Group AG.-------------------

The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.